The rally comes after the company announced the completion of a double-blind, randomized, placebo-controlled clinical trial evaluating its dietary supplement, Unbuzzd, for alcohol metabolism.

Quantum BioPharma invented unbuzzd™ and spun out its OTC version ... strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured ...

Results of data analysis show definitively that unbuzzd™ accelerated the rate at which Blood Alcohol Concentration (“BAC”) was reduced in study subjects, while simultaneously reducing the ...

Trial Confirms unbuzzd™ Dramatically Accelerates Alcohol Metabolism, Speeds the Reduction of Blood Alcohol Concentration, and Reduces Symptoms of Intoxication, Impairment and Hangover TORONTO, Feb. 04 ...